In other words this is not big deal. Bio-Tech companies file for patents on a regular basis and receive them. Yes it adds to their IP and in the long run is good for the company. It is not however going to be a major pps catalyst at this time do to the fact that it is commonplace for companies to file such.
News 
Market Data 
Discover 
AI
